Terms: = Germ cell tumor AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Treatment
124 results:
1. Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis.
Alhalabi OT; Dao Trong P; Kaes M; Jakobs M; Kessler T; Oehler H; König L; Eichkorn T; Sahm F; Debus J; von Deimling A; Wick W; Wick A; Krieg SM; Unterberg AW; Jungk C
J Neurooncol; 2024 Apr; 167(2):245-255. PubMed ID: 38334907
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas.
He Y; Zhao L; Tang X; Jiang Q; Zhao X; Cao Y
Ann Diagn Pathol; 2024 Feb; 68():152239. PubMed ID: 38006863
[TBL] [Abstract] [Full Text] [Related]
3. A phase I/II study of the safety and efficacy of [
Wild D; Grønbæk H; Navalkissoor S; Haug A; Nicolas GP; Pais B; Ansquer C; Beauregard JM; McEwan A; Lassmann M; Pennestri D; Volteau M; Lenzo NP; Hicks RJ
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):183-195. PubMed ID: 37721581
[TBL] [Abstract] [Full Text] [Related]
4. Suprasellar masquerader: Chordoid glioma.
Bhardwaj N; Salunke P; Singla N; Ahuja C; Gendle C; Gupta K
Clin Neuropathol; 2024; 43(1):23-28. PubMed ID: 37675487
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
6. Automated Brain 399FF">tumor Detection and Segmentation for treatment Response Assessment Using Amino Acid PET.
Gutsche R; Lowis C; Ziemons K; Kocher M; Ceccon G; Régio Brambilla C; Shah NJ; Langen KJ; Galldiks N; Isensee F; Lohmann P
J Nucl Med; 2023 Oct; 64(10):1594-1602. PubMed ID: 37562802
[TBL] [Abstract] [Full Text] [Related]
7. Lung cancer with breast metastasis: a case report and review of the literature.
Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
[TBL] [Abstract] [Full Text] [Related]
8. Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent 399FF">tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial.
Cappelli L; Khan MM; Kayne A; Poiset S; Miller R; Ali A; Niazi M; Shi W; Alnahhas I
Chin Clin Oncol; 2023 Jun; 12(3):23. PubMed ID: 37417289
[TBL] [Abstract] [Full Text] [Related]
9. [Regional variation in usage of ttf (Optune)].
Kinhult S; Tavelin B; Löfgren D; Rosenlund L; Sandström M; Strandeus M; Henriksson R
Lakartidningen; 2023 Jul; 120():. PubMed ID: 37401252
[TBL] [Abstract] [Full Text] [Related]
10. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine 399FF">tumors: Alternatives to RECIST.
de Mestier L; Resche-Rigon M; Dromain C; Lamarca A; La Salvia A; de Baker L; Fehrenbach U; Pusceddu S; Colao A; Borbath I; de Haas R; Rinzivillo M; Zerbi A; Funicelli L; de Herder WW; Selberherr A; Wagner AD; Manoharan P; De Cima A; Lybaert W; Jann H; Prinzi N; Faggiano A; Annet L; Walenkamp A; Panzuto F; Pedicini V; Pitoni MG; Siebenhuener A; Mayerhoefer ME; Ruszniewski P; Vullierme MP
J Neuroendocrinol; 2023 Jun; 35(6):e13311. PubMed ID: 37345276
[TBL] [Abstract] [Full Text] [Related]
11. Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map.
Fu M; Zhou Z; Huang X; Chen Z; Zhang L; Zhang J; Hua W; Mao Y
BMC Cancer; 2023 Jun; 23(1):544. PubMed ID: 37316802
[TBL] [Abstract] [Full Text] [Related]
12. Atypical thymic carcinoid 399FF">tumor with ectopic ACTH syndrome in a 33-year-old male patient: A rare case report and literature review.
Li LY; Zhao HY; Tong HC; Li YC; Xu HT; Ma S; Yang LH; Zhang WL; Wildes T; Wang E
Medicine (Baltimore); 2023 Jun; 102(22):e33847. PubMed ID: 37266641
[TBL] [Abstract] [Full Text] [Related]
13. Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy.
Lee S; Bennett AV; Zhou X; Betof Warner A; Trogdon JG; Kent EE; Lund JL
Pharmacoepidemiol Drug Saf; 2023 Sep; 32(9):988-1000. PubMed ID: 37095605
[TBL] [Abstract] [Full Text] [Related]
14. Urinary Neuroendocrine Neoplasms Treated in the "Modern Era": A Multicenter Retrospective Review.
Le BK; McGarrah P; Paciorek A; Mohamed A; Apolo AB; Chan DL; Reidy-Lagunes D; Hauser H; Rivero JD; Whitman J; Batty K; Zhang L; Raj N; Le T; Bergsland E; Halfdanarson TR
Clin Genitourin Cancer; 2023 Jun; 21(3):403-414.e5. PubMed ID: 37031047
[TBL] [Abstract] [Full Text] [Related]
15. The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
Lev-Ari S; Serzan M; Wu T; Ip A; Pascual L; Sinclaire B; Adams S; Marafelias M; Ayyagari L; Gill SK; Ma B; Zaemes JP; Della Pia A; Alaoui A; Madhavan S; Belouali A; Pecora A; Ahn J; Atkins MB; Shah NJ
Cancer; 2023 Jun; 129(12):1885-1894. PubMed ID: 36951119
[TBL] [Abstract] [Full Text] [Related]
16. circMMD reduction following 399FF">tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling.
Xu S; Luo C; Chen D; Tang L; Cheng Q; Chen L; Liu Z
J Exp Clin Cancer Res; 2023 Mar; 42(1):64. PubMed ID: 36932454
[TBL] [Abstract] [Full Text] [Related]
17. Modeling of intracranial 399FF">tumor treating fields for the treatment of complex high-grade gliomas.
Segar DJ; Bernstock JD; Arnaout O; Bi WL; Friedman GK; Langer R; Traverso G; Rampersad SM
Sci Rep; 2023 Jan; 13(1):1636. PubMed ID: 36717682
[TBL] [Abstract] [Full Text] [Related]
18. Safety and efficacy of tumour-treating fields (ttfields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-ttf System: a prospective post-approval study.
Nishikawa R; Yamasaki F; Arakawa Y; Muragaki Y; Narita Y; Tanaka S; Yamaguchi S; Mukasa A; Kanamori M
Jpn J Clin Oncol; 2023 Apr; 53(5):371-377. PubMed ID: 36647599
[TBL] [Abstract] [Full Text] [Related]
19. FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine 399FF">tumors.
Lacombe C; Perrier M; Hentic O; Brixi H; De Rycke O; Cros J; Rebours V; Cadiot G; Ruszniewski P; de Mestier L
J Neuroendocrinol; 2023 Jan; 35(1):e13227. PubMed ID: 36599808
[TBL] [Abstract] [Full Text] [Related]
20. TSPO PET signal using [
Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
[TBL] [Abstract] [Full Text] [Related]
[Next]
